Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics-Reference-Cited by-同舟云学术

Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics

Published:2015-03-01 Issue:5 Volume:72 Page:378-389
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Lafeuille Marie-Hélène¹,Grittner Amanda Melina¹,Fortier Jonathan¹,Muser Erik²,Fasteneau John²,Duh Mei Sheng³,Lefebvre Patrick⁴

Affiliation:

1. Groupe d’analyse, Ltée, Montréal, Canada

2. Health Economics and Outcomes Research, Janssen Scientific Affairs, LLC, Titusville, NJ

3. Analysis Group, Inc., Boston, MA

4. Groupe d’analyse, Ltée

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/72/5/378/28320942/ajhp0378.pdf

Reference44 articles.

1. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach;Wu;Psychol Med,2006

2. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services;Regier;Arch Gen Psychiatry,1993

3. Estimating the direct and indirect costs for community-dwelling patients with schizophrenia;Desai;J Pharm Heal Serv Res,2013

4. The economic burden of schizophrenia in the United States in 2002;Wu;J Clin Psychiatry,2005

5. Owens P Myers M Elixhauser A Brach C . Care of adults with mental health and substance abuse disorders in U.S. community hospitals, 2004 (January 2007). http://archive.ahrq.gov/data/hcup/factbk10/ (accessed 2014 Sep 23).

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With Schizophrenia;Psychiatric Services;2023-11-14

2. Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United States;Journal of Medical Economics;2023-04-06

3. Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies;Schizophrenia;2023-02-11

4. Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation;Advances in Therapy;2022-11-08

5. The design and process of a family and community-based intervention for relapse prevention in people living with schizophrenia in Iran;International Journal of Social Psychiatry;2022-10-06